Table 1.
Incidences per 28 days per million persons of cerebral venous sinus thrombosis and thrombocytopenia during the 28-day risk periods after COVID-19 vaccinations and during the unexposed time preceding the vaccinations.
Numbers of episodes provided in parentheses.
Fig 1.
From top to bottom shows the extraction of confirmed cerebral venous sinus thrombosis (CVST) in combination with thrombocytopenia. Note that three register-based CVST episodes, one of which confirmed, are included here but occurred after the risk periods and were not included in the pre-vaccinated time.
Table 2.
Characteristics and course of illness concerning patients and episodes of cerebral venous sinus thrombosis in unvaccinated subjects.